Item 5.07 Submission of Matters to a Vote of Security Holders.





Voting Results

At the Annual Meeting of Stockholders of Emmaus Life Sciences, Inc. ("we," "us," "our, "Emmaus" or the "company") held on December 8, 2022 (the "Annual Meeting"), the stockholders of the company voted on three proposals, all of which were approved. Management solicited proxies for the Annual Meeting pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended. There was no solicitation of proxies in opposition to management's nominees for election as directors identified in the proxy statement and all of management's nominees were elected to our Board of Directors.

As of the record date for the Annual Meeting, there were 49,558,501 shares of common stock outstanding and entitled to vote. The details of voting at the Annual Meeting are provided below.





Proposal 1:

To elect the five nominees named below to our Board of Directors, to serve until the next annual meeting of stockholders and until their successors are elected and qualified or their earlier retirement, resignation or removal:





                                                              Broker
                               Votes For    Votes Withheld   Non-Votes
Yutaka Niihara, M.D., M.P.H.   23,176,995      400,562       6,022,530
Willis C. Lee                  23,194,026      383,531       6,022,530
Seah Lim, M.D., Ph.D.          23,233,528      344,029       6,022,530
Wei Peu Derek Zen              23,229,478      348,079       6,022,530
Ian Zwicker                    23,233,428      344,129       6,022,530




Proposal 2:



                                                                                   Broker
                                   Votes For    Votes Against   Votes Withheld   Non-Votes
To approve the amendment to our
restated certificate of
incorporation to authorize our
Board of Directors in its
discretion to effect a reverse
stock split of the outstanding
shares of our common stock
within one year following the
Annual Meeting at a ratio of not
less than 1-for-5 nor greater
than 1-for-8                       28,880,074      679,945          40,068           0




  1






Proposal 3:

                                                                                   Broker
                                   Votes For    Votes Against   Votes Withheld   Non-Votes
To ratify the appointment of
Baker Tilly US, LLP as our
independent registered public
accounting firm for the fiscal
year ending December 31, 2022      29,515,739      50,244           34,104           0

Item 9.01 Financial Statements and Exhibits





(d) Exhibits

See the accompanying Index to Exhibits, which information is incorporated herein by reference.









  2

© Edgar Online, source Glimpses